Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,190,000 shares, a growth of 201.5% from the December 15th total of 394,700 shares. Based on an average daily trading volume, of 3,000,000 shares, the days-to-cover ratio is presently 0.4 days.

Aethlon Medical Price Performance

AEMD opened at $0.69 on Thursday. The stock’s 50 day moving average price is $0.51 and its 200 day moving average price is $0.44. The stock has a market cap of $9.60 million, a P/E ratio of -0.24 and a beta of 1.61. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.10.

Analyst Ratings Changes

Several equities analysts have recently commented on AEMD shares. HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Saturday, January 11th. They issued a “sell” rating for the company.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.